arrow_back Back to App

Opioid Addiction Treatment: Telehealth Prescribing for Controlled Substances.

The TREATS Act aims to increase access to opioid use disorder treatment by allowing practitioners to prescribe certain controlled substances (Schedules III, IV, or V) approved by the FDA after only one telehealth evaluation. This change removes the mandatory initial in-person visit for these specific medications, making it easier for patients, especially those in remote areas, to start treatment quickly. The goal is to leverage telemedicine to combat the opioid crisis.
Key points
Allows prescribing of FDA-approved controlled substances (Schedules III, IV, or V, excluding methadone) for opioid use disorder treatment following a single telehealth evaluation.
Removes the requirement for an initial in-person medical evaluation for prescribing these specific addiction treatment medications.
Defines 'telehealth evaluation' as a real-time, two-way interactive communication (audio-only or audio and video) conducted remotely by a practitioner.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_5163
Sponsor: Rep. Trone, David J. [D-MD-6]
Process start date: 2023-08-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Telehealth Response for E-prescribing Addiction Therapy Services Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_5163.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-08-04.

What are the main provisions?

Key points include:

  • Allows prescribing of FDA-approved controlled substances (Schedules III, IV, or V, excluding methadone) for opioid use disorder treatment following a single telehealth evaluation.
  • Removes the requirement for an initial in-person medical evaluation for prescribing these specific addiction treatment medications.
  • Defines 'telehealth evaluation' as a real-time, two-way interactive communication (audio-only or audio and video) conducted remotely by a practitioner.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Trone, David J. [D-MD-6].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

CATEGORIES

Health